# Irbesartan and Hydrochlorothiazide

NDC: 43547-331
Generic name: Irbesartan and Hydrochlorothiazide
Labeler / Manufacturer: Solco Healthcare US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20140301

FDA application: ANDA203072

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- IRBESARTAN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43547-331"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43547-331
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72fa8cd4-bc2a-4a7d-8feb-2d60e077d801